ANGELIA BERKOWITZ: Open Payments
NPI 1386870814 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,044 in 90 payments from 30 companies in 2025. Trend: 2023 $2,783 · 2024 $3,141 · 2025 $2,044
Food & beverage: $2,044
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 7 | $189 |
| Novartis Pharmaceuticals Corporation | 8 | $168 |
| GlaxoSmithKline, LLC. | 7 | $159 |
| Merck Sharp & Dohme LLC | 6 | $148 |
| Janssen Biotech, Inc. | 9 | $148 |
| Daiichi Sankyo Inc. | 10 | $136 |
| ABBVIE INC. | 3 | $83 |
| PFIZER INC. | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $77 |
| Astellas Pharma US Inc | 3 | $71 |
Products named: Enhertu, REBLOZYL, OJJAARA, KEYTRUDA, TIVDAK, TECVAYLI, VERZENIO, LONSURF.
Industry payments across TX — which companies pay providers there.
